Abstract
A great deal has changed since April 2003 when the human genome was first sequenced. Now, Enhanced Genomics (Cambridge, UK) has developed a 3D multi-omic profiling technology, GenLink, that combines molecular and computational techniques to enhance decision making at all stages of the drug discovery and development process.
Key Data
-
Publication Date28 January 2025
-
Primary AuthorNic Walker
-
SourceBioTechniques
-
LanguageEnglish
Click below to visit original source: